Price range: $83.00 through $120.00
Contents: Cagrilintide
Form: Lyophilized Powder
Purity: ≥ 99% pure
Emerging Research Evidence:
Enhances Weight Loss, Reduces Food Intake and Increases Feelings of Fullness, Improves Glycemic Control, Reduces Obesity and Type 2 Diabetes.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
Cagrilintide Overview
Cagrilintide is an investigational drug that mimics the natural hormone amylin to regulate appetite, promote satiety, and control blood glucose, contributing to weight loss. It is being investigated alone and in combination with Semaglutide (GLP-1) for enhanced weight-management effects. The most significant benefits have been shown in combination with the GLP-1 Semaglutide. Clinical trials and research are ongoing, and the claimed benefits are still emerging.
Cagrilintide Structure:
CAS Number: 1415456-99-3
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight: ~4409.0 g/mol
Parent Compound: Amylin (islet amyloid polypeptide, IAPP)
Monoisotopic Mass: ~4406.25 Da
Synonyms:
Research Areas:
Research-only note: Cagrilintide is not FDA-approved for therapeutic use; published effects are primarily preclinical and exploratory.
| Size | 5 mg, 10 mg |
|---|
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
